Clinical and Biological Signs of Dapagliflozin Overdose in ICU Patients With Metformin Poisoning

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCentre Hospitalier de Saint-Denis

About this trial

This study looks at patients admitted to intensive care for drug poisoning involving metformin, a common diabetes medication. Researchers will compare two groups: patients who overdosed on metformin alone and those who took both metformin and dapagliflozin, another diabetes drug. The goal is to find clinical or laboratory signs that could help doctors quickly recognize a dapagliflozin overdose in this context, which could improve treatment and patient outcomes.

Eligibility criteria

Qualifiers

Adults aged 18 years or older

Admission to an intensive care unit (ICU) due to acute drug poisoning

Metformin alone

Metformin in combination with dapagliflozin

Disqualifiers

Patients under 18 years of age

No exposure to metformin

Exposure to dapagliflozin without metformin

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed